CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Viage Therapeutics
Viage Therapeutics logo

Viage Therapeutics

Viage Therapeutics, a San Francisco-based neuroscience company, develops novel neurotherapeutics targeting the gut-brain axis for cognitive improvement and mental health.

San Francisco, CA, US🇺🇸
Founded
2018
Overview
Compare
Fundraising
Employees
Library

Viage Therapeutics, founded in 2018 and based in San Francisco, California, is a neuroscience company focused on developing novel neurotherapeutics. The company's core mission is to improve cognitive function and mental health by targeting the gut-brain axis. Their leading product, DGX-001, is a first-in-class oral drug candidate designed to modulate the vagus nerve through specific receptor interactions on enteroendocrine cells in the gut.

Viage Therapeutics is built on the pioneering research of Dr. Kousaku Ohinata from Kyoto University. The company has made significant strides in the field of neurotherapeutics, with DGX-001 representing a promising advancement in treating cognitive and mental health disorders. Their innovative approach has positioned them as a key player in the intersection of neuroscience and gastroenterology.

Viage Therapeutics - Similar Companies

Neurogastrx logo

Neurogastrx

neurogastrx.com

Voyager Therapeutics logo

Voyager Therapeutics

VistaGen Therapeutics logo

VistaGen Therapeutics

Enterin logo

Enterin

enterininc.com

Intact Therapeutics logo

Intact Therapeutics

Delix Therapeutics logo

Delix Therapeutics

Vian Therapeutics logo

Vian Therapeutics

viantx.com

Axial Therapeutics logo

Axial Therapeutics

Neurovia logo

Neurovia

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Vicinitas Therapeutics logo

Vicinitas Therapeutics

vicinitastx.com

Cognito Therapeutics logo

Cognito Therapeutics

cognitotx.com

Vasa Therapeutics logo

Vasa Therapeutics

Vitract logo

Vitract

vitract.com

Visum Pharma logo

Visum Pharma

visumpharmainc.com

Viage Therapeutics - Quick Facts

Who are Viage Therapeutics' competitors?

Companies similar to Viage Therapeutics include Neurogastrx, Voyager Therapeutics, VistaGen Therapeutics and Enterin.

When was Viage Therapeutics founded?

Viage Therapeutics was founded in 2018.

Where is Viage Therapeutics' headquarters located?

Viage Therapeutics' headquarters is located in San Francisco, CA, US.

When was Viage Therapeutics' last funding round?

Viage Therapeutics' most recent funding round was for $10M (USD) in January 2022.

How much disclosed funding has Viage Therapeutics raised?

As of Jan 6, 2022, Viage Therapeutics has disclosed funding of $10M (USD). Undisclosed round amounts are excluded.

How many employees does Viage Therapeutics have?

Viage Therapeutics has 2 employees as of Feb 4, 2024.

Viage Therapeutics - Classification

Ownership
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Neurotherapeutics
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research